The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Obstructions in Nanoparticles Conveyance, Nano-Drug Retention, and EPR Effect in Cancer Therapies
|
|
Author(s): Khalid Umar Fakhri (Department of Biosciences, Jamia Millia Islamia, New Delhi, India), Armiya Sultan (Jamia Millia Islamia, India), Md Mushtaque (Al-Falah University, India), Mohammad Raghibul Hasan (College of Applied Medical Sciences, Shaqra University, Al-Quwayiyah, Saudi Arabia), Sana Nafees (Jamia Millia Islamia, India), Zubair Bin Hafeez (Department of Biosciences, Jamia Millia Islamia, New Delhi, India), Md Zafaryab (Department of Biosciences, Jamia Millia Islamia, New Delhi, India), Md Rizwanullah (School of Pharmaceutical Education and Research, Jamia Hamdard, India), Deepti Sharma (Institute of Nuclear Medicine and Allied Sciences, India), Farhad Bano (National Institute of Immunology, New Delhi, India), Waleed Hassan AlMalki (Umm Al-Qura University, Saudi Arabia), Farhan Jalees Ahmad (School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India)and M. Moshahid Alam Rizvi (Department of Biosciences, Jamia Millia Islamia, New Delhi, India)
Copyright: 2021
Pages: 36
Source title:
Handbook of Research on Advancements in Cancer Therapeutics
Source Author(s)/Editor(s): Sumit Kumar (National Institute of Pathology, New Delhi, India), Moshahid Alam Rizvi (Jamia Millia Islamia, India)and Saurabh Verma (National Institute of Pathology, India)
DOI: 10.4018/978-1-7998-6530-8.ch026
Purchase
|
Abstract
In this chapter, the authors first review nano-devices that are mixtures of biologic molecules and synthetic polymers like nano-shells and nano-particles for the most encouraging applications for different cancer therapies. Nano-sized medications additionally spill especially into tumor tissue through penetrable tumor vessels and are then held in the tumor bed because of diminished lymphatic drainage. This procedure is known as the enhanced penetrability and retention (EPR) impact. Nonetheless, while the EPR impact is generally held to improve conveyance of nano-medications to tumors, it in certainty offers not exactly a 2-overlay increment in nano-drug conveyance contrasted with basic ordinary organs, bringing about medication concentration that is not adequate for restoring most malignant growths. In this chapter, the authors likewise review different obstructions for nano-sized medication conveyance and to make the conveyance of nano-sized medications to tumors progressively successful by expanding on the EPR impact..
Related Content
|
Genevieve Z. Steiner-Lim, Madilyn Coles, Kayla Jaye, Najwa-Joelle Metri, Ali S. Butt, Katerina Christofides, Jackson McPartland, Zainab Al-Modhefer, Diana Karamacoska, Ethan Russo, Tim Karl.
© 2023.
47 pages.
|
|
Mohd Kashif, Mohammad Waseem, Poornima D. Vijendra, Ashok Kumar Pandurangan.
© 2023.
28 pages.
|
|
Courtney R. Acker, Rana R. Zeine.
© 2023.
27 pages.
|
|
Mahesh Pattabhiramaiah, Shanthala Mallikarjunaiah.
© 2023.
16 pages.
|
|
Dhairavi Shah, Dhaara Shah, Yara Mohamed, Danna Rosas, Alyssa Moffitt, Theresa Hearn Haynes, Francis Cortes, Taunjah Bell Neasman, Phani kumar Kathari, Ana Villagran, Rana R. Zeine.
© 2023.
28 pages.
|
|
Mohammad Uzair, Hammad Qaiser, Muhammad Arshad, Aneesa Zafar, Shahid Bashir.
© 2023.
23 pages.
|
|
Akila Muthuramalingam, Ashok Kumar Pandurangan, Subhamoy Banerjee.
© 2023.
17 pages.
|
|
|